Bank of America’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
AF
AC
AIM
DSC
GIA
LCS
Bank of America's DRTS Position: Q1 2026 in Review
Bank of America reduced its Alpha Tau Medical (DRTS) stake by 6.2% in Q1 2026, selling an estimated $19.4K and leaving 41,392 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #5168.
Bank of America first reported a position in DRTS in Q1 2022 and has held it in 17 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.
- Bank of America held 41,392 shares of Alpha Tau Medical worth $293K as of Q1 2026.
- Bank of America sold 2,752 Alpha Tau Medical shares in Q1 2026, an estimated $19.4K.
- Alpha Tau Medical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5168 holding.
- Bank of America first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 17 quarters since.
- 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.